GenomeKey

Unlocking DNA

  • Biotech
Diagnostics

Member

Active

Status

2019

Founded

Seed

Development stage

  • Charity supporter
    Old Market
    Incubator residents

GenomeKey is transforming how healthcare clinicians diagnose and treat infections like sepsis to improve patient outcomes. Using cutting-edge machine learning and DNA sequencing, the company is developing a next-generation diagnostic device to identify bacterial genomes and determine their antimicrobial susceptibility directly from patient blood in just a few hours, rather than days. This enables clinicians to prescribe the right antibiotics for patients with much more efficiency and accuracy, reducing costs, minimising unnecessary antibiotic use and ultimately saving millions of lives from the world’s leading cause of death.

Founding team

Key contacts

Chief Information Security Officer

Arrow Right Corner
Arrow Right Corner

|